R. Ogilvie

Management of organic impurities in small molecule medicinal products: Deriving safe limits for use in early development

Andrew Teasdale, James Harvey, A. Teasdale, 2017, Regulatory toxicology and pharmacology : RTP.

Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances

R. Ogilvie, B. Leblanc, C. Charuel, 2012, International Journal of Pharmaceutical Medicine.

β,γ,-Unsaturated α-amino acid δ-lactones; precursors for polyhydroxy amino acids

M. Mahon, A. J. Floyd, R. Ogilvie, 1989 .

The effect of chromophore transposition on the stereochemical outcome of the intramolecular dioxenone photocycloaddition reaction

J. Winkler, P. Williard, N. Haddad, 1989 .

Synthesis of the C1-side chain of zaragozic acid D and progress towards a total synthesis

A. Armstrong, R. Ogilvie, P. Barsanti, 2003 .

AN IMPROVED SYNTHESIS OF THE UNIQUE ANTI-MIGRAINE AGENT CP-122,288 : A BROMINE ATOM PASSENGER IN AN INTRAMOLECULAR HECK REACTION

M. Wythes, R. Ogilvie, E. MacorJohn, 1996 .

Qualification of impurities based on metabolite data.

W. Muster, Chuang Lu, B. Trela, 2019, Regulatory toxicology and pharmacology : RTP.